Most employers have little idea what the pharmacy benefit managers they hire do with the money they exchange for the ...

As the immersive gaming platform scales its advertising and ecommerce offerings, Campaign explores how brands can best ...

Syneos Health, a 2024 MM+M Agency 100 honoree, appointed Costa Panagos as CEO. Syneos Health also announced two new ...

Like clothing, body types can go in and out of fashion — but this might be the first time a person’s figure is trending due to the rise of certain prescription drugs. Since GLP-1s like Ozempic and ...

Norstella LinQ establishes a throughline between the company’s various subsidiaries, utilizing capabilities from Citeline, ...

MIAMI: Earned media platform Muck Rack has launched improved media monitoring and PR reporting capabilities. The enhanced ...

As adland grapples with an ageing workforce, a new study by the Experience Advocacy Taskforce reveals the exodus of seasoned ...

Recent research suggests that the FDA’s black box warning for antidepressants may have had the opposite effect it intended.

Medicare’s costs could balloon by the low to middle tens of billions of dollars over 10 years due to the cost of covering GLP-1 drugs for obesity.

Join OptimizeRx chief commercial officer Theresa Greco as she highlights the steps pharma brands can take to make the synchronization shift — and why patient centricity is the key.

Costa Panagos will join Syneos Health’s board of directors and succeed Colin Shannon as CEO, effective immediately.

The lawsuit follows a ProPublica investigation that revealed that the heart transplant team at Newark Beth Israel let ...